View Archive »
About The Cover
The cover for issue 8 of Oncotarget features Figure 11, "The viability of TS543 human glioma spheroid cultures following treatments with CBD, ATM inhibitor (ATMi), and γ-irradiation (5 Gy), alone or in combination," by Ivanov, et al.
|
|
Table of Contents
Editorial
|
| Know your limits: RPA availability and chemoresistance in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.26607
|
| 800-802 |
|
| Pregnancies in young women with diagnosis and treatment of HER2positive breast cancer |
|
https://doi.org/10.18632/oncotarget.26611
|
| 803-804 |
|
| Antiphospholipid immune complexes as thrombosis risk marker |
|
https://doi.org/10.18632/oncotarget.26612
|
| 805-806 |
|
| Physical activity fragmentation as a potential phenotype of accelerated aging |
|
https://doi.org/10.18632/oncotarget.26631
|
| 807-809 |
Research Papers
|
| Transforming growth factor βinduced epithelialtomesenchymal signature predicts metastasisfree survival in nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.26574
|
| 810-824 |
|
| Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γirradiation in human glioblastoma cells |
|
https://doi.org/10.18632/oncotarget.26582
|
| 825-846 |
|
| Triplet chemotherapy with docetaxel cisplatin and S1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results |
|
https://doi.org/10.18632/oncotarget.26614
|
| 847-855 |
|
| Enhanced phosphatidylserineselective cancer therapy with irradiation and SapCDOPS nanovesicles |
|
https://doi.org/10.18632/oncotarget.26615
|
| 856-868 |
|
| Characterization and dynamics of specific T cells against nucleophosmin1 NPM1mutated peptides in patients with NPM1mutated acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.26617
|
| 869-882 |
Reviews
|
| Oxygen in the tumor microenvironment: effects on dendritic cell function |
|
https://doi.org/10.18632/oncotarget.26608
|
| 883-896 |
|
| Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosisinducing properties of human enzymes for the selective elimination of tumor cells |
|
https://doi.org/10.18632/oncotarget.26618
|
| 897-915 |
Corrections
|
| Correction: γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers |
|
https://doi.org/10.18632/oncotarget.26649
|
| 916-916 |
|
| Correction: The prognostic significance of combined androgen receptor ECadherin Ki67 and CK5/6 expression in patients with triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.26650
|
| 917-917 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
